Week of May 30, 2023 | Vol. 12, Issue 21

UPCOMING EVENTS

Events Hosted or Attended by Bourne Partners

INDUSTRY M&A ACTIVITY

Recent Transactions, Trading Comps, Market Reports, M&A Pipeline

Recent Transactions

An Overview of Transactions Within Market Sub-segments

Below are summaries and charts with the past week's transactions from the different healthcare sectors. For a detailed table showing data for each industry transaction click on any of the charts. Total transaction values are provided in USD millions.

Trading Comps

A Breakdown of Relevant Trading Multiples

This is a high-level breakdown of median revenue and EBITDA multiples for each of the specific sub sectors.

Market Reports

Insight Into Healthcare Related Industries

Pharma Services Sector Snapshot 1H 2022

August 2022

Market Insight Capital Markets Update

October 2022

M&A Pipeline

Representative Current Retained Sell-Side and Partnering Opportunities

Project Beach

Pharma Services | Sell-Side

Acquisition opportunity of Clinical Trial Services Provider

Project Elevate

Pharma Services | Capital Raise

Investment opportunity in Digital Health patient adherence platform

Project Ester

Consumer Health | Strategic Partnering 

Partnering opportunity for launch and commercialization of novel OTC dry eye product

Project Harold

Pharma Services | Sell-Side

Acquisition opportunity of U.S. based Sterile CDMO

Project Pine

Pharma Services | Capital Raise

Investment opportunity in sterile injectable Pharmaceutical Manufacturer 

Project Trident

Pharma | Buy-Side

Seeking generic liquids or established brands across all formats sold through the hospital / institutional channel

Featured Headlines

A Sampling of Industry Headlines

Indegene expands partnership with ConTIPI Medical Ltd to manage pelvic organ prolapse in women worldwide

Bourne Partners - May 24, 2023

Thousand Oaks Biologics and GeneQuantum Healthcare Signed A Strategic Partnership Agreement for ADC Drug Development

Business Wire - May 22, 2023

Societal CDMO Enters Agreement with Atossa Therapeutics to Provide Clinical Trial Services (CTS) for Innovative Selective Estrogen Receptor Modulator

Societal CDMO - May 23 2023

UCB, Veeva Partner to Advance Clinical Trial Efficiency

Contract Pharma - May 23, 2023

THREAD signs on with Allucent to launch DCTs for smaller biotechs

Fierce Biotech - May 24, 2023

Minaris Regenerative Medicine Streamlining Contract Manufacturing with Veeva Vault Quality Suite Applications

PR Newswire - May 24, 2023

Veeva in deal with UCB to leverage digital tools to help patient trial experiences

Fierce Biotech - May 24, 2023

Croda, Botanical Solution Partner on Sustainable Vaccine Adjuvant QS-21

Contract Pharma - May 24, 2023

TANNER NEWS

Global Named Patient Program for Zemdri

Tanner Pharma Group and Cipla Therapeutics Inc. have jointly launched an innovative Named Patient Program (NPP) for Zemdri (plazomicin) Injection. Tanner will be the supplier of Zemdri to healthcare providers in countries where the drug is not commercially available, expanding accessibility for patients 18 years of age or older for the treatment of Complicated Urinary Tract Infections (cUTI). Read the full press release here.

Let's Connect!

The Tanner team will be attending several networking events in the coming weeks. Let’s connect to discuss how our organizations can improve patient lives, together.